FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to haematology, cardiology and endocrinology, and concerns normalisation of the blood microvesicle level in arterial hypertension, abdominal obesity and type II diabetes mellitus. That is ensured by the specific low-calorie diet combined with graduated physical activity. In addition, Valsartan 80 mg once in the morning and Pioglitazone 30 mg once in the morning are prescribed. The length of treatment is at least 6 weeks.
EFFECT: method ensures the correction of the blood microvesicle level in the case patients, and consequently, reduced risk of thrombotic complications, such as infarction and stroke.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR BLOOD MICROVESCILE LEVEL CORRECTION IN ARTERIAL HYPERTENSION, DYSLIPIDEMIA AND TYPE II DIABETES MELLITUS | 2009 |
|
RU2400209C1 |
| METHOD FOR CORRECTION OF BLOOD MICROVESCILE LEVEL IN ARTERIAL HYPERTENSION AND ABDOMINAL OBESITY | 2009 |
|
RU2393858C1 |
| METHOD FOR DECREASING BLOOD MICROVESCILE LEVEL IN ARTERIAL HYPERTENSION AND IMPAIRED GLUCOSE TOLERANCE | 2009 |
|
RU2393859C1 |
| METHOD FOR ENHANCEMENT OF THROMBOCYTE ANTIOXIDANT PROOFNESS IN ARTERIAL HYPERTENSION CASES WITH METABOLIC SYNDROME | 2007 |
|
RU2331416C1 |
| METHOD FOR BLOOD MICROVESCILE LEVEL CORRECTION IN ABDOMINAL OBESITY AND IMPAIRED GLUCOSE TOLERANCE | 2009 |
|
RU2400204C1 |
| METHOD OF NORMALISATION OF THROMBOCYTE SUSCEPTIBILITY TO AGGREGATION STIMULATION AGENTS FOR ARTERIAL HYPERTENSION PATIENTS UNDER METABOLIC SYNDROME | 2007 |
|
RU2344815C1 |
| METHOD FOR CORRECTION OF BLOOD MICROVESCILE LEVEL IN DYSLIPIDEMIA AND ABDOMINAL OBESITY | 2009 |
|
RU2393856C1 |
| METHOD FOR NORMALISATION OF ADENOSINE DIPHOSPHATE AND ADENOSINE TRIPHOSPHATE SECRETION BY PLATELETS IN ARTERIAL HYPERTENSION PATIENTS WITH METABOLIC SYNDROME | 2007 |
|
RU2344855C1 |
| METHOD OF NORMALISING FUNCTIONAL REACTIVITY OF CARDIOVASCULAR SYSTEM IN CASE OF ARTERIAL HYPERTENSION WITH METABOLIC SYNDROME AND STAGE I-IIa HEART FAILURE | 2009 |
|
RU2403040C1 |
| METHOD OF THROMBOPLASTIN FORMATION FOR PATIENTS WITH METABOLIC SYNDROME | 2007 |
|
RU2332205C1 |
